These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9874 related articles for article (PubMed ID: 1140869)

  • 1. Prostaglandin synthesis inhibition: effect on bone changes and sarcoma tumor induction in balb/c mice.
    Strausser HR; Humes JL
    Int J Cancer; 1975 May; 15(5):724-30. PubMed ID: 1140869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indomethacin enhancement of spleen-cell responsiveness to mitogen stimulation in tumorous mice.
    Pelus LM; Strausser HR
    Int J Cancer; 1976 Nov; 18(5):653-60. PubMed ID: 186413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of indomethacin on Moloney sarcoma virus-induced tumors.
    Humes JL; Cupo JJ; Strausser HR
    Prostaglandins; 1974 Jun; 6(6):463-73. PubMed ID: 4366406
    [No Abstract]   [Full Text] [Related]  

  • 4. Subversion of immune system by tumor cells and role of prostaglandins.
    Plescia OJ; Smith AH; Grinwich K
    Proc Natl Acad Sci U S A; 1975 May; 72(5):1848-51. PubMed ID: 1057174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of the growth of a murine transplantable tumor, colon 26, by the prostaglandin synthetase inhibitor, indomethacin].
    Takahashi M; Narisawa T; Masuda T; Nagasawa O; Suzuki K; Yoshioka H; Koyama H
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2334-40. PubMed ID: 3111384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of murine tumor growth and prostaglandin synthesis by indomethacin.
    Fulton AM; Levy JG
    Int J Cancer; 1980 Nov; 26(5):669-73. PubMed ID: 6453846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of indomethacin in the control of prostaglandins, osteoclasts and bone destruction produced by VX2 carcinoma in rabbits.
    Galasko CS; Rawlins R; Bennett A
    Br J Cancer; 1979 Sep; 40(3):360-4. PubMed ID: 508564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of peritoneal carcinomatosis recurrence with a prostaglandin synthesis inhibitor, indomethacin].
    Narisawa T; Takahashi M; Masuda T; Nagasawa O; Koyama H
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2496-501. PubMed ID: 3476022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo effects of indomethacin on the growth of murine mammary tumors.
    Fulton AM
    Cancer Res; 1984 Jun; 44(6):2416-20. PubMed ID: 6722783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prostaglandin on experimental bone malignancy and on scintigrams of bone and marrow.
    Otsuka N; Ito Y; Nagai K; Terashima H; Yanagimoto S; Muranaka A
    J Nucl Med; 1981 May; 22(5):433-40. PubMed ID: 6452515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
    Kirchner H; Chused TM; Herberman RB; Holden HT; Lavrin DH
    J Exp Med; 1974 Jun; 139(6):1473-87. PubMed ID: 4598016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for multiple bone resorption-stimulating factors produced by normal human keratinocytes in culture.
    Fried RM; Voelkel EF; Rice RH; Levine L; Tashjian AH
    Endocrinology; 1988 Jun; 122(6):2467-75. PubMed ID: 2453341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus.
    Wood GW
    Cancer Res; 1976 Dec; 36(12):4552-7. PubMed ID: 1000500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-cancer treatment with prostaglandin synthetase inhibitor in animal models].
    Narisawa T; Takahashi M; Masuda T; Nagasawa O; Ogata N; Niwa M
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1329-35. PubMed ID: 3089171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of in vitro-stimulated immune lymphocytes in mice bearing Moloney murine sarcoma virus-induced primary tumor.
    Kimura H; Yamaguchi Y
    Gan; 1981 Feb; 72(1):72-80. PubMed ID: 7274651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of osteoclastic motility by prostaglandins I2, E1, E2 and 6-oxo-E1.
    Chambers TJ; Ali NN
    J Pathol; 1983 Mar; 139(3):383-97. PubMed ID: 6339702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma.
    Young MR; Hoover CS
    J Natl Cancer Inst; 1986 Aug; 77(2):425-9. PubMed ID: 2942724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of non-steroidal anti-inflammatory drugs of Moloney sarcoma virus inoculated mice.
    Inglot AD; Oleszak E
    Experientia; 1978 Dec; 34(12):1615-7. PubMed ID: 729732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 and 2-chloroadenosine act in concert to stimulate bone resorption in cultured murine calvarial bones.
    Lerner U; Fredholm BB
    Biochem Pharmacol; 1985 Apr; 34(7):937-40. PubMed ID: 3857042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes.
    Chieco-Bianchi L; Colombatti A; Collavo D; Sendo F; Aoki T; Fischinger PJ
    J Exp Med; 1974 Nov; 140(5):1162-79. PubMed ID: 4608945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 494.